NUCB2 and gastric cancer: Furthermore, at a cut‐off NUCB2/nesfatin‐1 value of 939.07 pg/ml, the optimal sensitivity and specificity were 100% and 83.3%, respectively, in discriminating patients with GC from healthy controls.